Please use this identifier to cite or link to this item:
Scopus Web of Science® Altmetric
Type: Journal article
Title: Pilot study examining the effect of cholesterol lowering on platelet nitric oxide responsiveness and arterial stiffness in subjects with isolated mild hypercholesterolaemia
Author: Stepien, J.
Prideaux, R.
Willoughby, S.
Chirkov, Y.
Horowitz, J.
Citation: Clinical and Experimental Pharmacology and Physiology, 2003; 30(7):507-512
Publisher: Blackwell Science Asia
Issue Date: 2003
ISSN: 0305-1870
Statement of
Jacqueline M Stepien, Rhonda M Prideaux, Scott R Willoughby, Yuliy Y Chirkov and John D Horowitz
Abstract: 1. Hypercholesterolaemia has been associated with impaired endothelial function. However, there are no available data as to whether hypercholesterolaemia is also associated with platelet dysfunction. 2. In a group of asymptomatic adults with (n = 16) and without (n = 13) mild hypercholesterolaemia, we evaluated inhibition of platelet aggregation in response to the nitric oxide (NO) donor sodium nitroprusside (SNP), as well as the augmentation index (AIx), a parameter of arterial stiffness that is impaired in the presence of endothelial dysfunction. 3. Neither SNP response nor AIx varied significantly between normocholesterolaemic (NC) and hypercholesterolaemic (HC) subjects. 4. Three months treatment with pravastatin (40 mg/day) in HC subjects lowered mean (±SEM) total cholesterol levels from 6.6 ± 0.2 to 5.5 ± 0.2 mmol/L. Platelet response to SNP increased in platelet-rich plasma and tended to increase in whole blood. The AIx did not change significantly. However, falls in low-density lipoprotein (P = 0.03) and total cholesterol (P = 0.08) correlated with reductions in AIx in individual subjects. 5. These data provide evidence that moderate reduction of cholesterol levels may improve platelet responses to NO, whereas improvement in arterial stiffness may be detectable only with more extensive and/or a prolonged reduction in cholesterol levels.
Keywords: Arteries; Blood Platelets; Humans; Hypercholesterolemia; Nitric Oxide; Pravastatin; Cholesterol; Nitric Oxide Donors; Anticholesteremic Agents; Pilot Projects; Vascular Resistance; Adult; Middle Aged; Female; Male
Description: The definitive version is available at
RMID: 0020030098
DOI: 10.1046/j.1440-1681.2003.03859.x
Published version:
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.